SCHEMBL22508346

SCHEMBL22508346

Cc1ccc(Nc2ncc(N)c(NCCCN)n2)cc1

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
STK17A Q9UEE5 20/20 0.65
STK17B O94768 11/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21364895 0.86 STK17A (0.81) STK17ASTK17B
SCHEMBL21365058 0.86 STK17A (0.78) STK17ASTK17B
SCHEMBL22508269 0.83 STK17A (0.79) STK17ASTK17B
SCHEMBL21365207 0.82 STK17A (0.82) STK17ASTK17B
SCHEMBL12705392 0.82 AURKA (0.58)
SCHEMBL21364902 0.80 STK17A (0.81) STK17ASTK17B
SCHEMBL20154736 0.79 STK17A (1.00) STK17ASTK17B
SCHEMBL20154742 0.79 STK17A (1.00) STK17ASTK17B
SCHEMBL20154845 0.79 STK17A (1.00) STK17ASTK17B
SCHEMBL21364889 0.78 STK17A (0.81) STK17ASTK17B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539951-B1 NOVEL PYRIMIDINE COMPOUND, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER AND INFLAMMATORY DISEASES KOREA RES INST CHEMICAL TECH (KR) 2020-10-07 EP disclosed